Zaremba Rabourn Amy's Form 4 filing
Opus Genetics, Inc. (IRD) · filed Mar 18, 2026
- Accession no.
- 0000905148-26-001382
- Filed
- Mar 18, 2026
- Trade date
- Mar 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $14.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zaremba Rabourn AmyCIK 0001832343 | Officer (Head of Fin. Quality Assurance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Common Stock | SSaleDisposed | −2,816 | $5.25 | −$14,784 | 190,312 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.